We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.92 | -0.63% | 145.90 | 147.175 | 145.95 | 146.70 | 6,182,984 | 01:00:00 |
From Apr 2019 to Apr 2024
Johnson & Johnson (JNJ) has hired Goldman Sachs Group Inc. (GS) to advise on the sale of its artificial sweetener brand Splenda, Reuters reported Wednesday, citing people familiar with the matter. The process is still at an early stage, one of the people said, with interested parties signing non disclosure agreements.
Full story at http://www.reuters.com/article/2014/12/03/us-johnson-johnson-m-a-splenda-exclusive-idUSKCN0JH1LG20141203
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
